Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of iNTS-GMMA vaccine in adults, children, and infants in Ghana
PACTR202305722094480Phase 2Unknown
- Sponsor
- GSK
- Start
- Jun 2023
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of iNTS-GMMA vaccine in invasive non-typhoidal salmonellosis (iNTS) (18 arms), sponsored by GSK. Status: unknown.
02
Drugs
iNTS-GMMA vaccine
03
Conditions
invasive non-typhoidal salmonellosis (iNTS)
Beyond the preview
Go deeper on PACTR202305722094480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202305722094480.